Updated recommendations from an international group of diabetes experts aim to inform diabetes educators about best practices ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

As the diabetes and weight loss market booms, more collaboration between pharma and medtech could help patients get the most ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

Injectable drugs require refrigeration when they are stored or transported, and the pill potentially opens up the market ...

However, this study was conducted in rats induced to have type 1 diabetes and was administered via injection. Additional research is needed to know if clove essential oil aromatherapy or topical ...

After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

I’m an old dog. There’s no denying it. I like to do things the way I have always done them. But I also like to keep current ...

Jaime Almandoz, MD, MBA, of UT Southwestern Medical Center, speaks on results of a study that investigated tirzepatide uptake ...